RPS6KB1 and cancer: It can activate many molecular signaling pathways, such as Wnt/β-catenin (42), EMT process (43), and mTOR/S6K (44) signaling pathways, leading to ECM remodeling, cancer cell proliferation and invasion, but inhibiting cell apoptosis.